Dr Ashanty Melo Rodriguez
Dr. Ashanty Melo Rodriguez completed her undergraduate degree in Clinical Biochemistry at the Universidad de las Americas Puebla, Mexico in 2012. Her final year project was entitled “Evaluation of the immunoreactivity of Ki-67 as indicator in brain tumours” under the supervision of Dr. Luz del Carmen Quiroz. The aim of this project was to evaluate if Ki-67 can be used to indicate the growth fraction of brain tumours in paediatric patients using immunohistochemistry.
Ashanty was then granted funding from the Government of Mexico to carry out a Ph.D. in the Department of Immunology, School of Medicine in Trinity College Dublin, under the supervision of Dr. Derek Doherty and Dr. Joanne Lysaght. Her Ph.D. project focused on the use of NKT cells as novel cellular based immunotherapies for oesophageal and gastric cancer patients. This project carried out detailed functional and phenotypic analysis of human NKT cells and importantly to determine the effect of different chemotherapy drugs and radiotherapy on the NKT -cell viability and function. She is currently a Posdoctoral researcher in Prof. Eleanor Molloy’s lab in the Dept of Paediatrics and Child Health, Trinity Translational Medicine Institute as part of a HRB grant. Her roll here is to study whether multiorgan dysfunction seen in neonates with neonatal encephalopathy persists into early childhood and assess the degree of multiorgan dysfunction following neonatal encephalopathy in early childhood and to plan detailed followup.